Telomere Diagnostics, Inc. is a privately held molecular testing company founded in 2010 by a group of four scientists including Dr. Elizabeth Blackburn, who won the Nobel Prize in Medicine in 2009 for her pioneering work in telomere biology. The company launched TeloYears, a simple genetic test that reveals the cellular age encoded in your DNA so you can know how well you’re aging. Our lab in Silicon Valley, California is regulated under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to perform high complexity clinical testing. There, we measure parts of chromosomes called telomeres, the protective caps on the ends of DNA strands that tend to shorten and fray with age. We use our own proprietary quantitative polymerase chain reaction (qPCR) assay, which is the world’s leading method of measuring Average Telomere Length (ATL). Beyond TeloYears, the company is actively developing other potential uses of ATL to address unmet clinical needs in cardiovascular disease, oncology, and in-vitro fertilization.
Robin Y Smith, President of Telomere Diagnostics is a visionary and strategist with a proven track record of successfully building high-energy innovative organizations.